These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36162951)

  • 1. Jujuboside A ameliorates tubulointerstitial fibrosis in diabetic mice through down-regulating the YY1/TGF-β1 signaling pathway.
    Liu YY; Li L; Ji B; Hao SL; Kuang XF; Cao XY; Yuan JY; Jiang ZZ; Qian ST; Wei CJ; Xu J; Yin XX; Lu Q; Yang TT
    Chin J Nat Med; 2022 Sep; 20(9):656-668. PubMed ID: 36162951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
    Gu LY; Yun-Sun ; Tang HT; Xu ZX
    J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis.
    Yang T; Hu Y; Chen S; Li L; Cao X; Yuan J; Shu F; Jiang Z; Qian S; Zhu X; Wei C; Wei R; Yan M; Li C; Yin X; Lu Q
    Cell Biol Toxicol; 2023 Apr; 39(2):391-413. PubMed ID: 35445903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1 was indispensable for the alleviation of quercetin on diabetic nephropathy-associated tubulointerstitial inflammation.
    Yang T; Hu Y; Jiang W; Pang J; Zhou Y; Zhang H; Yin Z; Jiang Z; Qian S; Wei C; Yan M; Zhu X; Wang T; Lu Q
    Phytomedicine; 2023 Mar; 111():154659. PubMed ID: 36641979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
    Li Z; Hong Z; Peng Z; Zhao Y; Shao R
    Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats.
    Chen J; Hu Y; Mou X; Wang H; Xie Z
    Life Sci; 2021 Jan; 265():118835. PubMed ID: 33253723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aqueous extract of Lycopus lucidus Turcz ameliorates streptozotocin-induced diabetic renal damage via inhibiting TGF-β1 signaling pathway.
    Yao Y; Yang J; Wang D; Zhou F; Cai X; Lu W; Hu C; Gu Z; Qian S; Guan X; Cao P
    Phytomedicine; 2013 Oct; 20(13):1160-7. PubMed ID: 23827664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of transient receptor potential melastatin 2 reduces renal fibrosis and inflammation by blocking transforming growth factor-β1-activated JNK1 activation in diabetic mice.
    Hu F; Yu Y; Lu F; Cheng X
    Aging (Albany NY); 2021 Nov; 13(22):24605-24620. PubMed ID: 34845114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanism of TGF-β1/SGK1 pathway in tubulointerstitial fibrosis of diabetic nephropathy.
    Miao XJ; Bi TT; Tang JM; Lv R; Gui DK; Yang XF
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10482-10488. PubMed ID: 31841202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress.
    Zhang W; Cheng Q; Yin L; Liu Y; Chen L; Jiang Z; Jiang X; Qian S; Li B; Wu M; Yin X; Wang T; Lu Q; Yang T
    Chem Biol Interact; 2024 Sep; 400():111157. PubMed ID: 39059604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
    Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
    Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Alpina oxyphylla extract on streptozotocin-induced kidney injure via regulating TGF-β1 and MyD88.
    Wu JX; Jia A; Tan YF; Xu H; Tian JP; Wang Y; Li HL; Gao BM; Li YH
    BMC Complement Med Ther; 2020 Jul; 20(1):217. PubMed ID: 32660472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy.
    Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y
    Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
    Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX
    Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction to: YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis.
    Yang T; Hu Y; Chen S; Li L; Cao X; Yuan J; Shu F; Jiang Z; Qian S; Zhu X; Wei C; Wei R; Yan M; Li C; Yin X; Lu Q
    Cell Biol Toxicol; 2023 Dec; 39(6):2787-2792. PubMed ID: 37115478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.